若您的瀏覽器無法支援 Javascript,並不會影響到網頁的閱讀
簡介最新公告資料申報統計分析資料下載相關連結回首頁English
 
:::

最新消息

[癌登第107003號通知文] 因應107年癌症登記實務作業之需求,請 貴院依說明段辦理

一、 本案係依衛生福利部國民健康署委託「台灣癌症登記工作計畫」辦理。

二、 依據最新WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2017)彙整而成。因2000年出版之ICD-O-3編碼不敷使用,且現行病理報告按最新組織型態記載,故提供最新病理組織型態編碼供醫院使用(附件更新自癌登107001號通知文內容),WHO 2017年新增編碼請於2017診斷年個案開始適用。注意事項如下:

(1) 新增性態碼為1(非惡性)的血液腫瘤編碼,原ICD-O-3無此類組織型態碼,僅提供參考用,請勿申報

(2) 新增編碼9715/3 Anaplstic large cell lymphoma, ALK-negative (原ICD-O-3編碼為9702/3)、9715/3 Breast implant-associated anaplastic large cell lymphoma、9749/3 Erdheim-Chester disease、9819/3 B-lymphoblastic leukaemia/lymphoma, BCR-ABL1-like、9877/3 AML with mutated NPM1 (原ICD-O-3編碼為9816/3)、9878/3 AML with biallelic mutation of CEBPA (原ICD-O-3編碼為9816/3)、9879/3 AML with mutated RUNX1、9912/3 AML with BCR-ABL1、9968/3 Myeloid/lymphoid neoplasms with PCM1-JAK2、9993/3 Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia。

(3) 性態碼3 (惡性)變為1 (非惡性)的血液腫瘤編碼如下:

WHO 2008

WHO 2017

97093

Cutaneous T-cell lymphoma, NOS (C44._)

97093

Primary cutaneous acral CD8-positive T-cell lymphoma

Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma

Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma

Primary cutaneous CD4-positive small/medium T-cell lymphoma

97091

Primary cutaneous CD4-positive small/medium T-cell lymphoproliferative disorder

97183

Lymphomatoid papulosis (C44._)

97181

Lymphomatoid papulosis (C44._)

Primary cutaneous CD30-positive T-cell lymphoproliferative disorders (C44._)

97183

Primary cutaneous CD30-positive T-cell lymphoproliferative disorders (C44._)

Primary cutaneous anaplastic large cell lymphoma (C44._)

Primary cutaneous anaplastic large cell lymphoma (C44._)

97253

Hydroa vacciniforme-like lymphoma

97251

Hydroa vacciniforme-like lymphoproliferative disorder

97513

Langerhans cell histiocytosis, NOS

97511

Langerhans cell histiocytosis, NOS

Langerhans cell histiocytosis, mono-ostotic

Langerhans cell histiocytosis, monostotic

Langerhans cell histiocytosis, poly-ostotic

Langerhans cell histiocytosis, polystotic

Langerhans cell histiocytosis, disseminated

97513

Langerhans cell histiocytosis, disseminated

99713

Polymorphic post-transplant lymphoproliferative disorder

99711

Polymorphic post-transplant lymphoproliferative disorder

 

三、 ICD-O-3組織型態編碼:

(1) 新增8801/3-8804/3 New term,即Undifferentiated (未分化) 描述。

(2) 原編碼9871/3 Acute myeloid leukemia, t(16;16)(p13;q11)有誤,請修正為Acute myeloid leukemia, t(16;16)(p13;q22)。

四、 依癌登中心諮詢病理專家意見:

(1)修正8830/3 Undifferentiated high-grade pleomorphic sarcoma於原發部位為BONE適用;若發生於其他部位,則以8802/3 Undifferentiated pleomorphic sarcoma申報。

(2)有關惡性腦膜瘤個案(M-code 953),其發生部位應編碼為腦膜(C70 Meminges)。

 

[癌登第107003號通知文全文下載]

 

 

 

 

Back